Detalles de la búsqueda
1.
The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis.
BMC Cancer
; 24(1): 21, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38166684
2.
Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study.
BMC Geriatr
; 24(1): 282, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38528444
3.
The impact of chemotherapy and survival prediction by machine learning in early Elderly Triple Negative Breast Cancer (eTNBC): a population based study from the SEER database.
BMC Geriatr
; 22(1): 268, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35361134
4.
Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis.
BMC Cancer
; 24(1): 205, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38350924
5.
Efficacy and safety of first-line therapy in patients with HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials.
J Cancer Res Clin Oncol
; 150(1): 21, 2024 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38244085
6.
Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis.
Expert Rev Anticancer Ther
; : 1-13, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693054
7.
Tyrosine kinase inhibitors in HER2-positive breast cancer brain metastases: A systematic review and meta-analysis.
Cancer Med
; 12(14): 15090-15100, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37255389
8.
Epidemiology and a Predictive Model of Prognosis Index Based on Machine Learning in Primary Breast Lymphoma: Population-Based Study.
JMIR Public Health Surveill
; 9: e45455, 2023 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37169516
9.
Efficacy and safety of neoadjuvant therapy for triple-negative breast cancer: a Bayesian network meta-analysis.
Expert Rev Anticancer Ther
; 22(10): 1141-1151, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36103214
10.
Efficacy and safety of neoadjuvant therapy for HER2-positive early breast cancer: a network meta-analysis.
Ther Adv Med Oncol
; 13: 17588359211006948, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33868462
Resultados
1 -
10
de 10
1
Próxima >
>>